- Home
- DYN vs PRGS Comparison
DYN vs PRGS Comparison
Compare DYN & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- PRGS
- Stock Information
- Founded
- DYN 1984
- PRGS 1981
- Country
- DYN United States
- PRGS United States
- Employees
- DYN N/A
- PRGS N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- PRGS Computer Software: Prepackaged Software
- Sector
- DYN Health Care
- PRGS Technology
- Exchange
- DYN Nasdaq
- PRGS Nasdaq
- Market Cap
- DYN 2.6B
- PRGS 2.4B
- IPO Year
- DYN 2020
- PRGS 1991
- Fundamental
- Price
- DYN $9.91
- PRGS $58.98
- Analyst Decision
- DYN Strong Buy
- PRGS Buy
- Analyst Count
- DYN 12
- PRGS 7
- Target Price
- DYN $47.73
- PRGS $74.43
- AVG Volume (30 Days)
- DYN 2.1M
- PRGS 831.8K
- Earning Date
- DYN 05-01-2025
- PRGS 03-31-2025
- Dividend Yield
- DYN N/A
- PRGS 0.59%
- EPS Growth
- DYN N/A
- PRGS N/A
- EPS
- DYN N/A
- PRGS 1.27
- Revenue
- DYN N/A
- PRGS $806,739,000.00
- Revenue This Year
- DYN N/A
- PRGS $30.56
- Revenue Next Year
- DYN N/A
- PRGS $3.29
- P/E Ratio
- DYN N/A
- PRGS $46.53
- Revenue Growth
- DYN N/A
- PRGS 12.85
- 52 Week Low
- DYN $8.94
- PRGS $48.00
- 52 Week High
- DYN $47.45
- PRGS $70.56
- Technical
- Relative Strength Index (RSI)
- DYN 33.59
- PRGS 61.80
- Support Level
- DYN $10.72
- PRGS $50.68
- Resistance Level
- DYN $12.00
- PRGS $55.74
- Average True Range (ATR)
- DYN 0.80
- PRGS 1.63
- MACD
- DYN -0.13
- PRGS 0.43
- Stochastic Oscillator
- DYN 25.06
- PRGS 95.90
Stock Price Comparison Chart: DYN vs PRGS
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.